(Urgent) Less than $4 Biotech Announces a Breakthrough in Leukemia

(Urgent) Less than $4 Biotech Announces a Breakthrough in Leukemia Early stage Biotechs can potentially yield significant attention. Those who take interest in these companies are usually the first to notice their products that have the possibility to disrupt big markets. One little Biotech (~ $4) just announced the deployment of a breakthrough in fusion gene map technology for the $15Bn Leukemia treatment market. Don't Wait: Click here for the company name and ticker symbol! Huge Upside Potential With "Staggering" Solar Demand Global solar demand is "staggering" right now, according to Bloomberg. Solar installations are set to grow 30% this year alone. And the boom is just beginning, with increasing adoption of solar by commercial, non-profit, and public entities. With only 1% of commercial electricity demand served by on-site solar globally, there is HUGE opportunity for growth. See How Investors Could Benefit * Landmine stocks to ditch immediately [AD] * Gold is about to SOAR – here's what you need to do [AD] * Deep Dive: 10 Simple Investments That Can Turn Your Portfolio Into An Income Dynamo

Stockguru LLC 711 SW 24th Ave Boynton, Beach, FL 33435 This email is being sent from Investing Chatter. If you no longer wish to receive Investing Chatter emails, please click to unsubscribe.

DISCLAIMER: Stocks and options trading have large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stocks and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell stocks or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed in this report. The past performance of any trading system or methodology is not necessarily indicative of future results. All trades, patterns, charts, systems, etc., discussed in this report are for illustrative purposes only and not to be construed as specific advisory recommendations. Information contained in this correspondence is intended for informational purposes only and was obtained from sources believed to be reliable. Information is in no way guaranteed. No guarantee of any kind is implied or possible where projections of future conditions are attempted.